SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Sep-24 8:36 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 13-Sep-24 | Gift | 15,000 | -- | -- | (4%) 405.55K to 390.55K | |
13-Jun-24 9:45 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-24 | Gift | 39,000 | -- | -- | (8%) 489.69K to 450.69K | |
13-Jun-24 9:45 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-24 | Gift | 45,852 | -- | -- | (10%) 450.69K to 404.83K | |
16-May-24 9:53 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 14-May-24 | Option Exercise | 22,489 | $103.02 | $2,316,840.00 | 5% 489.69K to 512.17K | |
16-May-24 9:53 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 14-May-24 | Planned Option Sale | 22,489 | $212.88 | $4,787,400.00 | (4%) 512.17K to 489.69K | |
11-Dec-23 7:25 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 07-Dec-23 | Disposition (other) | 1,556,590 | -- | -- | (76%) 2.05M to 489.69K | |
11-Dec-23 7:25 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 30-Jan-23 | Gift | 3,557 | -- | -- | (< 1%) 2.05M to 2.05M | |
02-Feb-22 10:00 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 31-Dec-21 | Gift | 3,000 | -- | -- | (< 1%) 1.98M to 1.98M | |
07-Dec-21 4:30 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 03-Dec-21 | Disposition (other) | 824,172 | -- | -- | (29%) 2.81M to 1.98M | |
11-Feb-21 10:00 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 30-Dec-20 | Gift | 15,000 | -- | -- | (< 1%) 2.75M to 2.73M | |
04-Sep-20 9:06 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 04-Sep-20 | Disposition (other) | 1,545,460 | -- | -- | (35%) 4.36M to 2.81M | |
19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 19-Aug-20 | Market Sale Duplicate | 7,303 | $107.64 | $786,095.00 | (< 1%) 4.23M to 4.23M | |
19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 18-Aug-20 | Market Sale Duplicate | 10,197 | $110.03 | $1,121,980.00 | (< 1%) 4.24M to 4.23M | |
19-Aug-20 7:40 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 17-Aug-20 | Market Sale Duplicate | 12,500 | $110.73 | $1,384,120.00 | (< 1%) 4.26M to 4.24M | |
29-May-20 4:51 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 27-May-20 | Disposition (other) | 412,236 | -- | -- | (9%) 4.67M to 4.26M | |
24-Feb-20 7:32 PM View: | Dermira, Inc. (DERM) | 20-Feb-20 | Disposition | 3,542,650 | $18.75 | $66,424,600.00 | (100%) 3.54M to 0 | |
13-Dec-19 2:08 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 13-Dec-19 | Market Sale | 1,200,000 | $105.47 | $126,564,000.00 | (22%) 5.38M to 4.18M | 2% |
14-Jun-19 5:16 PM View: | Dermira, Inc. (DERM) | 12-Jun-19 | Option Exercise Duplicate | 3,000 | -- | -- | < 1% 3.54M to 3.54M | |
19-Nov-18 6:09 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 19-Nov-18 | Market Purchase | 2,000 | $124.69 | $249,387.00 | < 1% 296.07K to 298.07K | 8% |
06-Nov-18 5:01 PM View: | Twist Bioscience Corp (TWST) | 02-Nov-18 | Conversion | 66,771 | -- | -- | 100% 0 to 66.77K | |
14-Jun-18 5:46 PM View: | Dermira, Inc. (DERM) | 13-Jun-18 | Option Exercise | 3,000 | -- | -- | < 1% 3.54M to 3.54M | |
12-Jun-18 9:02 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-18 | Market Sale | 5,908 | $287.46 | $1,698,310.00 | < 1% 5.65M to 5.65M | (53%) |
12-Jun-18 9:02 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 11-Jun-18 | Market Sale | 274,092 | $287.46 | $78,790,496.00 | (5%) 5.65M to 5.38M | 53% |
14-Aug-17 8:56 PM View: | Dermira, Inc. (DERM) | 14-Aug-17 | Market Purchase | 10,000 | $23.95 | $239,460.00 | < 1% 3.53M to 3.54M | (68%) |
14-Aug-17 8:56 PM View: | Dermira, Inc. (DERM) | 10-Aug-17 | Market Purchase | 20,000 | $22.57 | $451,470.00 | < 1% 3.51M to 3.53M | (66%) |
26-Jul-16 5:55 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 22-Jul-16 | Grant | 296,067 | -- | -- | 100% 0 to 296.07K | |
26-Jul-16 5:55 PM View: | Synta Pharmaceuticals Corp. (MDGL) | 22-Jul-16 | Grant | 5,657,850 | -- | -- | 1911% 296.07K to 5.95M | |
08-Oct-14 4:18 PM View: | Dermira, Inc. (DERM) | 08-Oct-14 | Conversion Duplicate | 3,420,300 | -- | -- | 19839% 17.24K to 3.44M | |
08-Oct-14 4:18 PM View: | Dermira, Inc. (DERM) | 08-Oct-14 | Purchase Duplicate | 69,112 | $16.00 | $1,105,790.00 | 2% 3.44M to 3.51M | |
10-Jun-11 4:50 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 09-Jun-11 | Option Exercise | 36,145 | -- | -- | 6% 606.11K to 642.26K | |
30-Mar-09 1:21 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 27-Mar-09 | Market Purchase | 5,000 | $2.14 | $10,724.00 | < 1% 601.11K to 606.11K | (99%) |
30-Mar-09 1:20 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 26-Mar-09 | Market Purchase | 15,000 | $2.10 | $31,515.00 | 3% 586.11K to 601.11K | (99%) |
23-Dec-08 4:38 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 22-Dec-08 | Market Purchase | 2,900 | $1.76 | $5,103.00 | < 1% 542.61K to 545.51K | (98%) |
23-Dec-08 4:37 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 19-Dec-08 | Market Purchase | 25,000 | $1.75 | $43,785.00 | 5% 517.61K to 542.61K | (98%) |
19-Dec-08 6:01 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 18-Dec-08 | Market Purchase | 26,500 | $1.90 | $50,304.70 | 5% 491.11K to 517.61K | (98%) |
17-Dec-08 7:18 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 17-Dec-08 | Market Purchase | 13,000 | $1.91 | $24,852.80 | 3% 478.11K to 491.11K | (98%) |
17-Dec-08 7:18 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 16-Dec-08 | Market Purchase | 11,900 | $1.96 | $23,310.00 | 3% 466.21K to 478.11K | (99%) |
14-Jan-08 6:33 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 11-Jan-08 | Market Purchase | 12,600 | $3.98 | $50,095.50 | 3% 453.61K to 466.21K | (99%) |
10-Jan-08 4:11 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 09-Jan-08 | Market Purchase | 20,000 | $4.24 | $84,731.00 | 5% 433.61K to 453.61K | (99%) |
07-Jan-08 3:10 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 04-Jan-08 | Market Purchase | 11,300 | $4.22 | $47,675.20 | 3% 422.31K to 433.61K | (99%) |
07-Jan-08 3:09 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 03-Jan-08 | Market Purchase | 20,000 | $4.27 | $85,466.00 | 5% 402.31K to 422.31K | (99%) |
31-Aug-07 5:40 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 30-Aug-07 | Market Purchase | 5,336 | $5.90 | $31,477.00 | 1% 396.98K to 402.32K | (100%) |
31-Aug-07 5:40 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 30-Aug-07 | Market Purchase | 8 | $5.74 | $45.92 | (< 1%) 402.32K to 402.31K | 99% |
31-Aug-07 5:32 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 29-Aug-07 | Market Purchase | 352 | $5.75 | $2,023.12 | < 1% 396.62K to 396.97K | (99%) |
16-Aug-07 7:36 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 16-Aug-07 | Market Purchase | 327 | $5.48 | $1,793.20 | < 1% 396.29K to 396.62K | (99%) |
16-Aug-07 7:36 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 14-Aug-07 | Market Purchase | 41 | $5.50 | $225.50 | < 1% 396.25K to 396.29K | (99%) |
14-Aug-07 5:18 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 10-Aug-07 | Market Purchase | 972 | $5.50 | $5,346.00 | < 1% 395.27K to 396.25K | (99%) |
30-Apr-07 5:42 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 30-Apr-07 | Private Purchase | 79,498 | $6.33 | $503,222.00 | 25% 315.78K to 395.27K | |
28-Apr-06 1:19 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 26-Apr-06 | Conversion | 102,610 | $0.70 | $71,827.00 | 100% 102.61K to 205.22K | |
28-Apr-06 1:19 PM View: | Poniard Pharmaceuticals, Inc. (PARD.PK) | 26-Apr-06 | Private Purchase | 1,792,050 | $0.70 | $1,254,440.00 | 873% 205.22K to 2.0M |